← Studies & programmes
Myelin repairNot tested in peopleResearch, not an established treatment
Scripps/Lairson: testing a two-molecule combination in models
Published by MyelinWatch:
Scripps / Lairson combination · Researchers combined two small molecules because together they increased myelin repair in experimental models. The combination is still at an early development stage.
What is being studied
Researchers combined two small molecules because together they increased myelin repair in experimental models. The combination is still at an early development stage.
Research stage
Not tested in people
Work remains in the laboratory and product development; a first safety study is planned.
What we know so far
The reported effect is from laboratory and animal models only. No benefit in people with MS has been shown.
What this means for patients today
This combination is not a treatment. More development and safety checks are needed before a human study could be considered.
- Treatment or approach
- A fixed-dose combination of two small molecules
- How it is intended to work
- Combines two molecules that produced a stronger effect together in experimental models
- Published by MyelinWatch
- Last substantive MyelinWatch update